Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98011597 | 9801159 | 7 | F | 20121218 | 20160805 | 20140107 | 20160811 | EXP | US-PFIZER INC-2014001232 | PFIZER | 59.00 | YR | F | Y | 65.77000 | KG | 20160811 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98011597 | 9801159 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, 1X/DAY | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
98011597 | 9801159 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 150 MG, 1X/DAY | 21992 | 150 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
98011597 | 9801159 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, DAILY | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | |||||||
98011597 | 9801159 | 4 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 200 MG, DAILY | N12688 | 21992 | 200 | MG | PROLONGED-RELEASE TABLET | ||||||
98011597 | 9801159 | 5 | C | ROZEREM | RAMELTEON | 1 | 8 MG, 1X/DAY (QHS) | 0 | 8 | MG | QD | ||||||||
98011597 | 9801159 | 6 | C | BENICAR/HCTZ 20/12.5 | 2 | UNK | 0 | ||||||||||||
98011597 | 9801159 | 7 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | 60 MG, 1X/DAY | 0 | 60 | MG | QD | ||||||||
98011597 | 9801159 | 8 | C | CADUET | AMLODIPINE BESYLATEATORVASTATIN CALCIUM | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
98011597 | 9801159 | 9 | C | MELOXICAM. | MELOXICAM | 1 | 7.5 MG, 1X/DAY | 0 | 7.5 | MG | QD | ||||||||
98011597 | 9801159 | 10 | C | XANAX | ALPRAZOLAM | 1 | 1 MG, TWICE DAILY, AS NEEDED | 0 | 1 | MG | |||||||||
98011597 | 9801159 | 11 | C | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | 70 MG, 1X/DAY | 0 | 70 | MG | QD | ||||||||
98011597 | 9801159 | 12 | C | NEURONTIN | GABAPENTIN | 1 | 300 MG, QHS, AS NEEDED | 0 | 300 | MG | |||||||||
98011597 | 9801159 | 13 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 100 MG, 1X/DAY (ONCE AT NIGHT TIME) | 0 | 100 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
98011597 | 9801159 | 1 | Depression |
98011597 | 9801159 | 5 | Insomnia |
98011597 | 9801159 | 10 | Anxiety |
98011597 | 9801159 | 11 | Attention deficit/hyperactivity disorder |
98011597 | 9801159 | 12 | Pain |
98011597 | 9801159 | 13 | Depression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
98011597 | 9801159 | HO |
98011597 | 9801159 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
98011597 | 9801159 | Anxiety | |
98011597 | 9801159 | Breast mass | |
98011597 | 9801159 | Crying | |
98011597 | 9801159 | Depression | |
98011597 | 9801159 | Drug withdrawal syndrome | |
98011597 | 9801159 | Feeling abnormal | |
98011597 | 9801159 | Intentional product misuse | |
98011597 | 9801159 | Renal neoplasm | |
98011597 | 9801159 | Suicidal ideation | |
98011597 | 9801159 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
98011597 | 9801159 | 1 | 20120716 | 20130114 | 0 | |
98011597 | 9801159 | 2 | 20130115 | 201311 | 0 | |
98011597 | 9801159 | 3 | 2013 | 2013 | 0 | |
98011597 | 9801159 | 4 | 2013 | 0 | ||
98011597 | 9801159 | 5 | 20101016 | 0 | ||
98011597 | 9801159 | 10 | 20120105 | 0 | ||
98011597 | 9801159 | 11 | 20101016 | 0 | ||
98011597 | 9801159 | 12 | 20120404 | 0 |